Patents by Inventor Mourad Kaghad

Mourad Kaghad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFIED SR-P70 PROTEIN
    Publication number: 20110020951
    Abstract: The invention relates to new nucleic acid sequences of the family of tumor-suppressing genes related to the gene for the p53 protein, and to corresponding protein sequences.
    Type: Application
    Filed: September 20, 2010
    Publication date: January 27, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Daniel CAPUT, Pascual FERRARA, Ahmed Mourad KAGHAD
  • Purified SR-p70 protein
    Patent number: 7838648
    Abstract: The invention relates to new nucleic acid sequences of the family of tumor-suppressing genes related to the gene for the p53 protein, and to corresponding protein sequences.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: November 23, 2010
    Assignee: Sanofi Aventis
    Inventors: Daniel Caput, Pascual Ferrara, Ahmed Mourad Kaghad
  • PURIFIED SR-P70 PROTEIN
    Publication number: 20090258409
    Abstract: The invention relates to new nucleic acid sequences of the family of tumor-suppressing genes related to the gene for the p53 protein, and to corresponding protein sequences.
    Type: Application
    Filed: May 12, 2009
    Publication date: October 15, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Daniel CAPUT, Pascual FERRARA, Ahmed Mourad KAGHAD
  • Purified SR-p70 protein
    Patent number: 7557187
    Abstract: The invention relates to new nucleic acid sequences of the family of tumour-suppressing genes related to the gene for the p53 protein, and to the corresponding protein sequences.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: July 7, 2009
    Assignee: sanofi-aventis
    Inventors: Daniel Caput, Pascual Ferrara, Ahmed Mourad Kaghad
  • Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms
    Patent number: 5652123
    Abstract: The subject of the present invention is a protein having cytokine type activity, or a precursor of this protein, which comprises the following amino acid sequence (a1): ##STR1## in which Xaa represents Asp or Gly.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: July 29, 1997
    Assignee: Elf Sanofi
    Inventors: Daniel Caput, Pascual Ferrara, Jean-Claude Guillemot, Mourad Kaghad, Christine Labit-Le Bouteiller, Pascal Leplatois, Marilyn Magazin, Adrian Minty
  • Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells
    Patent number: 5541098
    Abstract: The invention concerns a new urate oxidase activity protein which has the following sequence (SEQ ID NO:1): ##STR1## optionally preceded by a methionine, or in that it may present a degree of substantial homology with this sequence.The invention is also aimed at medicines containing this protein as well as the genetic engineering implements to obtain it.
    Type: Grant
    Filed: September 28, 1994
    Date of Patent: July 30, 1996
    Assignee: Sanofi
    Inventors: Daniel Caput, Pascual Ferrara, Jean-Claude Guillemot, Mourad Kaghad, Richard LeGoux, G erard Loison, Elisabeth Larbre, Johannes Lupker, Pascal Leplatois, Marc Salome, Patrick Laurent
  • Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells
    Patent number: 5382518
    Abstract: The invention concerns a new urate oxidase activity protein which has the following sequence:______________________________________ Ser Ala Val Lys Ala Ala Arg Tyr Gly Lys Asp Asn Val Arg Val Tyr Lys Val His Lys Asp Glu Lys Thr Gly Val Gln Thr Val Tyr Glu Met Thr Val Cys Val Leu Leu Glu Gly Glu Ile Glu Thr Ser Tyr Thr Lys Ala Asp Asn Ser Val Ile Val Ala Thr Asp Ser Ile Lys Asn Thr Ile Tyr Ile Thr Ala Lys Gln Asn Pro Val Thr Pro Pro Glu Leu Phe Gly Ser Ile Leu Gly Thr His Phe Ile Glu Lys Tyr Asn His Ile His Ala Ala His Val Asn Ile Val Cys His Arg Trp Thr Arg Met Asp Ile Asp Gly Lys Pro His Pro His Ser Phe Ile Arg Asp Ser Glu Glu Lys Arg Asn Val Gln Val Asp Val Val Glu Gly Lys Gly Ile Asp Ile Lys Ser Ser Leu Ser Gly Leu Thr Val Leu Lys Ser Thr Asn Ser Gln Phe Trp Gly Phe Leu Arg Asp Glu Tyr Thr Thr Leu Lys Glu Thr Trp Asp Arg Ile Leu Ser Thr Asp Val Asp Ala Thr Trp Gln Trp Lys Asn Phe Ser Gly Leu Gln Glu Val Arg Ser His Val Pro Lys Phe Asp Ala Thr Trp Ala Thr Ala Arg Glu Val Thr Leu Lys Thr Phe Ala Glu Asp Asn
    Type: Grant
    Filed: July 28, 1992
    Date of Patent: January 17, 1995
    Assignee: Sanofi
    Inventors: Daniel Caput, Pascual Ferrara, Jean-Claude Guillemot, Mourad Kaghad, Richard Legoux, Gerard Loison, Elisabeth Larbre, Johannes Lupker, Pascal Leplatois, Marc Salome, Patrick Laurent